The Quantellect read.As of Nov 19, 2026, 11 active firms cover Universal Health Services Inc: 4 rate it Buy or better, 7 sit at Neutral, and 0 rate it Sell or worse, a neutral consensus. Targets span $166.00 to $310.00, a moderate spread. The average target of $196.27 sits 6% above the current $186.00. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 3 to 4 over recent months. On the fundamentals, the Street sees consensus EPS building from about $5.65 next quarter toward $23.01 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS11 active firms
Neutral
Strong Buy00%
Buy436%
Neutral764%
Sell00%
Strong Sell00%
Based on 11 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$196.27
+5.5% upside
Average target across 11 active firms as of Nov 19, 2026 vs $186.00 current
Highest Target$310.00
Average Target$196.27
Lowest Target$166.00
Detailed analyst forecasts for UHS
Showing 1–11 of 11 named analysts shown · 11 active firms in the rating projection
As of Nov 19, 2026, 4 of 11 active firms rate UHS a Buy (7 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
UHS EPS & revenue forecast
EPS · NEXT QUARTER
$5.65
Range $4.87 – $6.41 · 8 analysts · +1% YoY
Next period, 8 analysts expect Universal Health Services Inc to earn $5.65 a share (range $4.87 – $6.41), versus $5.62 a year earlier. Full-year consensus is $22.45, growing to $23.01 the year after.
REVENUE · NEXT QUARTER
$4.7B
Range $4.6B – $4.8B · 8 analysts · +5% YoY
Revenue is expected to reach $4.7B (range $4.6B – $4.8B), +5.4% year-over-year. Full-year consensus is $18.6B, rising to $19.5B next year.
Top analysts covering Universal Health Services Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on UHS.
#1
Stephen Baxter
Wells Fargo · Rank #63
Neutral
$170.00-8.6% to target
Overall win rate
47%
+ Follow
#2
Ben Hendrix
RBC Capital · Rank #150
Neutral
$183.00-1.6% to target
Overall win rate
44%
+ Follow
#3
Sarah James
Cantor Fitzgerald · Rank #159
Neutral
$194.00+4.3% to target
Overall win rate
37%
+ Follow
#4
AR
A.J. Rice
UBS · Rank #365
Buy
$250.00+34.4% to target
Overall win rate
35%
+ Follow
#5
Andrew Mok
Barclays · Rank #385
Neutral
$168.00-9.7% to target
Overall win rate
39%
+ Follow
UHS stock forecast FAQ
What is UHS's average 12-month price target?+
The 11 active firms with a live target average $196.27 for Universal Health Services Inc over the next 12 months, ranging from a $310.00 high to a $166.00 low, as of Nov 19, 2026.
Is UHS stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 11 active firms as of Nov 19, 2026, 4 rate it Buy or Strong Buy, 7 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for UHS?+
The Street-high target is $310.00 (UBS), and the Street-low is $166.00 (Baird). The average of all 11 active-firm targets is $196.27.
How many active Wall Street firms cover UHS?+
11 active firms have a recognized rating on Universal Health Services Inc as of Nov 19, 2026, and 11 active firms carry a live 12-month price target.
Who is the most accurate analyst covering UHS?+
Among analysts who currently cover UHS, Stephen Baxter of Wells Fargo has the strongest overall Quantellect track record (Rank #63). Their current call is Neutral with a $170.00 target.
What is Universal Health Services Inc's projected EPS for next quarter?+
The consensus estimate is $5.65 per share (range $4.87 – $6.41) across 8 analysts. Full-year EPS is projected at $22.45, rising to $23.01 the following year.
How much revenue is Universal Health Services Inc expected to report next quarter?+
Consensus revenue is $4.7B (range $4.6B – $4.8B). Full-year revenue is projected at $18.6B, growing to $19.5B next year.
Have analysts been upgrading or downgrading UHS lately?+
As of Nov 19, 2026, 4 of 11 active firms rate UHS a Buy (7 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their UHS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.